Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
2 passages
REFERENCES Alade SL, Brown RE, and Paquet A Jr, "Polysorbate 80 and E-Ferol Toxicity," Pediatrics , 1986, 77(4):593-7. [PubMed 3960626 ] Anderson BJ, Keeley SR, and Johnson ND, “Caval Thrombolysis in Neonates Using Low Doses of Recombinant Human Tissue-Type Plasminogen Activator,” Anaesth Intensive Care , 1991, 19(1):22-7. [PubMed 1901463 ] Anderson B, Urs P, Tudehope D, et al, "The Use of Recombinant Tissue Plasminogen Activator in the Management of Infective Intracardiac Thrombi in Pre-term Infants With Thrombocytopaenia," J Paediatr Child Health , 2009, 45(10):598-601. [PubMed 19825023 ] Andrew M, Brooker L, Leaker M, et al, “Fibrin Clot Lysis by Thrombolytic Agents is Impaired in Newborns Due to a Low Plasminogen Concentration,” Thromb Haemost , 1992, 68(3):325-30. [PubMed 1440499 ] Cada DJ, Levien T, and Baker DE, “Alteplase,” Hospital Pharmacy , 2002, 37(2): 148-54. Centers for Disease Control (CDC), "Unusual Syndrome With Fatalities Among Premature Infants: Association With a New Intravenous Vitamin E Product," MMWR Morb Mortal Wkly Rep , 1984, 33(14):198-9. [PubMed 6423951 ] Choi M, Massicotte MP, Marzinotto V, et al, “The Use of Alteplase to Restore Patency of Central Venous Lines in Pediatric Patients: A Cohort Study,” J Pediatr , 2001, 139(1):152-6. [PubMed 11445811 ] Davis SN, Vermeulen L, Banton J, et al, “Activity and Dosage of Alteplase Dilution for Clearing Occlusions of Venous-Access Devices,” Am J Health Syst Pharm , 2000, 57(11):1039-45. [PubMed 10876745 ] Doyle E, Britto J, Freeman J, et al, “Thrombolysis With Low Dose Tissue Plasminogen Activator,” Arch Dis Child , 1992, 67(12):1483-4. [PubMed 1489229 ] Farnoux C, Camard O, Pinquier D, et al, “Recombinant Tissue-Type Plasminogen Activator Therapy of Thrombosis in 16 Neonates,” J Pediatr , 1998, 133(1):137-40. [PubMed 9672527 ] Frazin BS, “Maximal Dilution of Activase,” Am J Hosp Pharm , 1990, 47(5):1016. [PubMed 2110773 ] Generali J and Cada DJ, “Alteplase (t-PA) Bolus: Occluded Catheters,” Hospital Pharmacy , 2001, 36(1):93-103. Hartmann J, Hussein A, Trowitzsch E, et al, "Treatment of Neonatal Thrombus Formation With Recombinant Tissue Plasminogen Activator: Six Years Experience and Review of the Literature," Arch Dis Child Fetal Neonatal Ed , 2001, 85(1):F18-22. [PubMed 11420316 ] Kothari SS, Varma S, and Wasir S, “Thrombolytic Therapy in Infants and Children,” Am Heart J , 1994, 127(3):651-7. [PubMed 8122615 ]
Hartmann J, Hussein A, Trowitzsch E, et al, "Treatment of Neonatal Thrombus Formation With Recombinant Tissue Plasminogen Activator: Six Years Experience and Review of the Literature," Arch Dis Child Fetal Neonatal Ed , 2001, 85(1):F18-22. [PubMed 11420316 ] Kothari SS, Varma S, and Wasir S, “Thrombolytic Therapy in Infants and Children,” Am Heart J , 1994, 127(3):651-7. [PubMed 8122615 ] Levy M, Benson LN, Burrows PE, et al, “Tissue Plasminogen Activator for the Treatment of Thromboembolism in Infants and Children,” J Pediatr , 1991, 118(3):467-72. [PubMed 1900334 ] Monagle P, Chalmers E, Chan A, et al, "Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)," Chest , 2008, 133(6 Suppl):887S-968S. [PubMed 18574281 ] Monagle P, Chan A, Massicotte P, et al, "Antithrombotic Therapy in Children: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy," Chest , 2004, 126(3 Suppl):645S-687S. [PubMed 15383489 ] Monagle P, Michelson AD, Bovill E, et al, “Antithrombotic Therapy in Children,” Chest , 2001, 119(1 Suppl):344S-370S. [PubMed 11157659 ] Nowak-Gottl U, Auberger K, Halimeh S, et al, “Thrombolysis in Newborns and Infants,” Thromb Haemost , 1999, 82 (Suppl 1):112-6. [PubMed 10695499 ] Ponec D, Irwin D, Haire WD, et al, “Recombinant Tissue Plasminogen Activator (Alteplase) for Restoration of Flow in Occluded Central Venous Access Devices: A Double-Blind Placebo-Controlled Trial - The Cardiovascular Thrombolytic to Open Occluded Lines (COOL) Efficacy Trial,” J Vasc Intern Radiol , 2001, 12(8):951-5. [PubMed 11487675 ] Soylu H, Brandão LR, and Lee KS, "Efficacy of Local Instillation of Recombinant Tissue Plasminogen Activator for Restoring Occluded Central Venous Catheters in Neonates," J Pediatr , 2010, 156(2):197-201. [PubMed 19969306 ] Weiner GM, Castle VP, DiPietro MA, et al, “Successful Treatment of Neonatal Arterial Thromboses With Recombinant Tissue Plasminogen Activator,” J Pediatr , 1998, 133(1):133-6. [PubMed 9672526 ] Topic 13363 Version 36.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-122.72.80.101-F770B2E4D0-S244013.14]